Home LiteratureArticle Details
PMID: 8627772 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures.

Journal of virology ·Vol. 70 ·No. 5 ·1996-05-00 ·Pages 2963-73

McBride MS, Panganiban AT

Abstract

We analyzed the leader region of human immunodeficiency virus type 1 (HIV-1) RNA to decipher the nature of the cis-acting E/psi element required for encapsidation of viral RNA into virus particles. Our data indicate that, for RNA encapsidation, there are at least two functional subregions in the leader region. One subregion is located at a position immediately proximal to the major splice donor, and the second is located between the splice donor and the beginning of the gag gene. This suggests that at least two discrete cis-acting elements are recognition signals for encapsidation. To determine whether specific putative RNA secondary structures serve as the signal(s) for encapsidation, we constructed primary base substitution mutations that would be expected to destabilize these potential structures and second-site compensatory mutations that would restore secondary structure. Analysis of these mutants allowed the identification of two discrete hairpins that facilitate RNA encapsidation in vivo. Thus, the HIV-1 E/psi region is a multipartite element composed of specific and functional RNA secondary structures. Compensation of the primary mutations by the second-site mutations could not be attained in trans. This indicates that interstrand base pairing between these two stem regions within the hairpins does not appear to be the basis for HIV-1 RNA dimer formation. Comparison of the hypothetical RNA secondary structures from 10 replication-competent HIV-1 strains suggests that a subset of the hydrogen-bonded base pairs within the stems of the hairpins is likely to be required for function in cis.

MeSH Terms
Base Composition Base Sequence Capsid/biosynthesis,metabolism Cloning, Molecular DNA Primers HIV-1/genetics,physiology HeLa Cells Humans Models, Structural Molecular Sequence Data Mutagenesis, Site-Directed Nucleic Acid Conformation Protein Sorting Signals/biosynthesis RNA, Viral/chemistry,metabolism Transfection Virion/genetics,metabolism Virus Replication
Chemicals
DNA Primers Protein Sorting Signals RNA, Viral
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
McBride M S
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison 53706, USA.
Panganiban A T
References (58)
58 references, click to expand
  1. Analytical study of avian reticuloendotheliosis virus dimeric RNA generated in vivo and in vitro.
    J Virol. 1992 Dec;66(12):7245-52 PMID: 1331519
  2. Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biochemical properties of mutant TK15 and mutant-induced transformants.
    J Virol. 1984 Jul;51(1):154-62 PMID: 6202881
  3. Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs.
    J Virol. 1993 Jan;67(1):178-88 PMID: 8380070
  4. Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.
    J Mol Biol. 1993 Jan 20;229(2):382-97 PMID: 8429553
  5. Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine, and human retroviruses.
    J Virol. 1993 Apr;67(4):1830-9 PMID: 8383213
  6. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles.
    J Virol. 1993 May;67(5):2681-8 PMID: 8474168
  7. Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3393-7 PMID: 8475087
  8. Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein.
    Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5219-23 PMID: 8506369
  9. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.
    J Virol. 1993 Jul;67(7):3997-4005 PMID: 8510213
  10. Maturation of dimeric viral RNA of Moloney murine leukemia virus.
    J Virol. 1993 Sep;67(9):5443-9 PMID: 8350405
  11. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
    J Virol. 1993 Oct;67(10):6159-69 PMID: 8371356
  12. Mode of dimerization of HIV-1 genomic RNA.
    Biochemistry. 1993 Oct 26;32(42):11453-7 PMID: 8218211
  13. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
    J Virol. 1993 Dec;67(12):7190-200 PMID: 8230441
  14. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.
    Cell. 1983 May;33(1):153-9 PMID: 6678608
  15. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs.
    J Virol. 1985 May;54(2):401-7 PMID: 3989912
  16. A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging.
    J Virol. 1986 Jul;59(1):163-7 PMID: 3012114
  17. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  18. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.
    J Virol. 1987 May;61(5):1639-46 PMID: 3502707
  19. Effect of internal viral sequences on the utility of retroviral vectors.
    J Virol. 1987 May;61(5):1647-50 PMID: 3033290
  20. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line.
    J Virol. 1987 Sep;61(9):2675-83 PMID: 3039161
  21. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes.
    J Virol. 1988 Sep;62(9):3328-33 PMID: 2841485
  22. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions.
    J Virol. 1988 Oct;62(10):3802-6 PMID: 3418786
  23. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein.
    J Virol. 1989 Apr;63(4):1558-68 PMID: 2926863
  24. On finding all suboptimal foldings of an RNA molecule.
    Science. 1989 Apr 7;244(4900):48-52 PMID: 2468181
  25. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.
    J Virol. 1989 Sep;63(9):4085-7 PMID: 2760989
  26. Improved predictions of secondary structures for RNA.
    Proc Natl Acad Sci U S A. 1989 Oct;86(20):7706-10 PMID: 2479010
  27. Predicting optimal and suboptimal secondary structure for RNA.
    Methods Enzymol. 1990;183:281-306 PMID: 1690335
  28. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.
    J Virol. 1990 May;64(5):1920-6 PMID: 2109098
  29. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants.
    J Virol. 1990 May;64(5):2416-20 PMID: 2325207
  30. Retroviral RNA packaging: sequence requirements and implications.
    Curr Top Microbiol Immunol. 1990;157:125-52 PMID: 2394131
  31. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.
    J Virol. 1990 Oct;64(10):5230-4 PMID: 2204725
  32. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.
    J Virol. 1990 Nov;64(11):5270-6 PMID: 2214018
  33. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.
    J Mol Biol. 1990 Dec 5;216(3):689-99 PMID: 2124274
  34. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector.
    J Virol. 1991 Jan;65(1):532-6 PMID: 1985215
  35. Specificity of retroviral RNA packaging.
    J Virol. 1991 Jan;65(1):71-80 PMID: 1985218
  36. Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus.
    J Virol. 1992 Feb;66(2):632-40 PMID: 1309906
  37. Human immunodeficiency virus vectors for inducible expression of foreign genes.
    J Virol. 1992 May;66(5):2731-9 PMID: 1560523
  38. RNA packaging signal of human immunodeficiency virus type 1.
    Virology. 1992 Jun;188(2):590-9 PMID: 1585635
  39. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.
    J Virol. 1992 Jul;66(7):4144-53 PMID: 1602537
  40. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.
    J Virol. 1994 Jun;68(6):3784-93 PMID: 8189516
  41. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.
    J Virol. 1994 Jun;68(6):3888-95 PMID: 7910642
  42. Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro.
    Proc Natl Acad Sci U S A. 1994 May 24;91(11):4945-9 PMID: 8197162
  43. Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein.
    Virology. 1994 Jul;202(1):233-46 PMID: 8009834
  44. A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA.
    Biochemistry. 1994 Nov 15;33(45):13464-74 PMID: 7947755
  45. Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA.
    J Biol Chem. 1994 Nov 4;269(44):27486-93 PMID: 7961663
  46. RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.
    J Virol. 1995 Apr;69(4):2101-9 PMID: 7884856
  47. Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retroviruses.
    J Virol. 1995 Apr;69(4):2175-86 PMID: 7884866
  48. Dimerization of HIV-1Lai RNA at low ionic strength. An autocomplementary sequence in the 5' leader region is evidenced by an antisense oligonucleotide.
    J Biol Chem. 1995 Apr 7;270(14):8209-16 PMID: 7713927
  49. A short sequence upstream of the 5' major splice site is important for encapsidation of HIV-1 genomic RNA.
    Virology. 1994 Jan;198(1):336-40 PMID: 8259668
  50. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA.
    EMBO J. 1994 Feb 1;13(3):713-26 PMID: 8313915
  51. Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.
    Nucleic Acids Res. 1994 Jan 25;22(2):145-51 PMID: 8121797
  52. Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation.
    AIDS Res Hum Retroviruses. 1992 Sep;8(9):1669-77 PMID: 1457211
  53. Evidence for 30-40S RNA as precursor of the 60-70S RNA of Rous sarcoma virus.
    Proc Natl Acad Sci U S A. 1973 Feb;70(2):401-5 PMID: 4119788
  54. The oncornavirus maturation process: quantitative correlation between morphological changes and conversion of genomic virion RNA.
    Intervirology. 1976;7(4-5):211-24 PMID: 188781
  55. Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: characterization of a deletion in the provirus.
    J Virol. 1980 Nov;36(2):450-6 PMID: 6253670
  56. Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene.
    Proc Natl Acad Sci U S A. 1982 Oct;79(19):5986-90 PMID: 6310558
  57. Identification of a sequence likely to be required for avian retroviral packaging.
    Virology. 1983 Jul 30;128(2):505-11 PMID: 6310871
  58. cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus.
    J Virol. 1983 Dec;48(3):667-75 PMID: 6313966
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-05-00
Pages
2963-73
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC190155
Subset
IM
Grants
NIAID NIH HHS · R01 AI34733 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]